Altered molecular adaptation to exercise in children with type 1 diabetes: Beyond hypoglycemia

Pediatric Diabetes

Volumn 10, Issue 3, 2009, Pages 213-226

  Rosa, Jaime S ^a,b   Galassetti, Pietro R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Counterregulatory; Diabetes; Exercise; Growth; Inflammation

Indexed keywords

GROWTH FACTOR; GROWTH HORMONE; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN C;

ADAPTATION; BODY WEIGHT; CARBOHYDRATE METABOLISM; CHILD; CYTOKINE RELEASE; EXERCISE; GENE ACTIVATION; GENE EXPRESSION; HEALTH STATUS; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; LEUKOCYTE; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW;

ADAPTATION, PSYCHOLOGICAL; CHILD; CHILD BEHAVIOR; DIABETES MELLITUS, TYPE 1; EXERCISE; FEMALE; GROWTH HORMONE; HEALTH STATUS; HOMEOSTASIS; HUMANS; HYPOGLYCEMIA; INSULIN-LIKE GROWTH FACTOR I; MALE; OXIDATIVE STRESS;

EID: 65449141674     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2008.00452.x     Document Type: Review

References (176)

1. Laaksonen DE, Atalay M, Niskanen LK et al. Aerobic exercise and the lipid profile in type 1 diabetic men: A randomized controlled trial. Med Sci Sports Exerc 2000: 32: 1541-1548.
2. Hannon TS, Rao G, Arslanian SA. Childhood obesity and type 2 diabetes mellitus. Pediatrics 2005: 116: 473-480.
3. Berenson GS, Srinivasan SR, Bao W et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med 1998: 338: 1650-1656.
4. Lakka TA, Venalainen JM, Rauramaa R, Salonen R, Tuomilehto J, Salonen JT. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction in men. N Engl J Med 1994: 330: 1549-1554.
5. Larson EB, Wang L, Bowen JD et al. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann Intern Med 2006: 144: 73-81.
6. Strong WB, Malina RM, Blimkie CJ et al. Evidence based physical activity for school-age youth. Pediatrics 2005: 146: 732-737.
7. Timmons BW, Tarnopolsky MA, Bar-Or O. Immune responses to strenuous exercise and carbohydrate intake in boys and men. Pediatr Res 2004: 56: 227-234.
8. Nemet D, Oh Y, Kim HS, Hill M, Cooper DM. Effect of intense exercise on inflammatory cytokines and growth mediators in adolescent boys. Pediatrics 2002: 110: 681-689.
9. Urso ML, Clarkson PM. Oxidative stress, exercise, and antioxidant supplementation. Toxicology 2003: 189: 41-54.
10. Nikolaidis M, Kyparos A, Hadziioannou M et al. Acute exercise markedly increases blood oxidative stress in boys and girls. Appl Physiol Nutr Metab 2007: 32: 197-205.
11. Cryer PE. Glucose counterregulation: Prevention and correction of hypoglycemia in humans. Am J Physiol Endocrinol Metab 1993: 264: E149-E155.
12. Galassetti PR, Iwanaga K, Crisostomo M, Zaldivar FP, Larson J, Pescatello A. Inflammatory cytokine, growth factor and counterregulatory responses to exercise in children with type 1 diabetes and healthy controls. Pediatr Diabetes 2006: 7: 16-24.
13. Connolly PH, Caiozzo VJ, Zaldivar F et al. Effects of exercise on gene expression in human peripheral blood mononuclear cells. J Appl Physiol 2004: 97: 1461-1469.
14. Nieman DC, Davis JM, Henson DA et al. Muscle cytokine mRNA changes after 2.5 h of cycling: Influence of carbohydrate. Med Sci Sports Exerc 2005: 37: 1283-1290.
15. Cooper DM, Nemet D, Galassetti P. Exercise, stress, and inflammation in the growing child: From the bench to the playground. Curr Opin Pediatr 2004: 16: 286-292.
16. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993: 329: 977-986.
17. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000: 342: 381-389.
18. The Diabetes Control and Complications Trial (DCCT)/The Epidemiology of Diabetes Interventions and Complications (EDIC) Research Groups. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). Pediatrics 2001: 139: 804-812.
19. The Writing Team for the Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Research Group.Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002: 287: 2563-2569.
20. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005: 353: 2643-2653.
21. Hambrecht R, Wolf A, Gielen S et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med 2000: 342: 454-460.
22. Pedersen O, Beck-Nielsen H, Heding L. Increased insulin receptors after exercise in patients with insulin-dependent diabetes mellitus. N Engl J Med 1980: 302: 886-892.
23. Smith AG, Muscat GE. Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease. Int J Biochem Cell Biol 2005: 37: 2047-2063.
24. Teran-Garcia M, Rankinen T, Koza RA, Rao DC, Bouchard C. Endurance training-induced changes in insulin sensitivity and gene expression. Am J Physiol Endocrinol Metab 2005: 288: E1168-E1178.
25. Cooper DM, Radom-Aizik S, Schwindt C, Zaldivar F Jr. Dangerous exercise: lessons learned from dysregulated inflammatory responses to physical activity. J Appl Physiol 2007: 103: 700-709.
26. Cryer PE. Glucose counterregulation in man. Diabetes 1981: 30: 261-264.
27. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care 2003: 26: 1902-1912.
28. Hayashi T, Wojtaszewski JF, Goodyear LJ. Exercise regulation of glucose transport in skeletal muscle. Am J Physiol Endocrinol Metab 1997: 273: E1039-E1051.
29. Camacho RC, Galassetti P, Davis SN, Wasserman DH. Glucoregulation during and after exercise in health and insulin-dependent diabetes. Exerc Sport Sci Rev 2005: 33: 17-23.
30. Marliss EB, Vranic M. Intense exercise has unique effects on both insulin release and its roles in glucoregulation: Implications for diabetes. Diabetes 2002: 51: S271-S283.
31. De Feo P, Perriello G, Torlone E et al. Contribution of adrenergic mechanisms to glucose counterregulation in humans. Am J Physiol Endocrinol Metab 1991: 261: E725-E736.
32. De Feo P, Perriello G, Torlone E et al. Demonstration of a role for growth hormone in glucose counterregulation. Am J Physiol Endocrinol Metab 1989: 256: E835-E843.
33. De Feo P, Perriello G, Torlone E et al. Contribution of cortisol to glucose counterregulation in humans. Am J Physiol Endocrinol Metab 1989: 257: E35-E42.
34. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 2005: 98: 1154-1162.
35. Galassetti PR, Iwanaga K, Pontello AM, Zaldivar FP, Flores RL, Larson JK. Effect of prior hyperglycemia on IL-6 responses to exercise in children with type 1 diabetes. Am J Physiol Endocrinol Metab 2006: 290: E833-E839.
36. Petersen KF, Price TB, Bergeron R. Regulation of net hepatic glycogenolysis and gluconeogenesis during exercise: Impact of type 1 diabetes. J Clin Endocrinol Metab 2004: 89: 4656-4664.
37. The Diabetes Research in Children Network Study Group. The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes. Diabetes Care 2006: 29: 20-25.
38. Wanke T, Auinger M, Formanek D et al. Defective endogenous opioid response to exercise in type I diabetic patients. Metabolism 1996: 45: 137-142.
39. Bjorgaas M, Vik T, Sand T et al. Counterregulatory hormone and symptom responses to hypoglycaemia in diabetic children. Diabet Med 1997: 14: 433-441.
40. Hoffman RP, Singer-Granick C, Drash AL, Becker DJ. Plasma catecholamine responses to hypoglycemia in children and adolescents with IDDM. Diabetes Care 1991: 14: 81-88.
41. Gerich JE, Langlois M, Noacco C, Karam JH, Forsham PH. Lack of glucagon response to hypoglycemia in diabetes: Evidence for an intrinsic pancreatic alpha cell defect. Science 1973: 182: 171-173.
42. Ross LA, Warren RE, Kelnar CJ, Frier BM. Pubertal stage and hypoglycaemia counterregulation in type 1 diabetes. Arch Dis Child 2005: 90: 190-194.
43. Banarer S, Mc Gregor VP, Cryer PE. Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response. Diabetes 2002: 51: 958-965.
44. Mc Crimmon RJ, Evans ML, Jacob RJ et al. AICAR and phlorizin reverse the hypoglycemia-specific defect in glucagon secretion in the diabetic BB rat. Am J Physiol Endocrinol Metab 2002: 283: E1076-E1083.
45. Karavanaki K. Coexistence of impaired indices of autonomic neuropathy and diabetic nephropathy in a cohort of children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2003: 16: 79-90.
46. Galassetti P, Tate D, Neill RA, Morrey S, Wasserman DH, Davis SN. Effect of antecedent hypoglycemia on counterregulatory responses to subsequent euglycemic exercise in type 1 diabetes. Diabetes 2003: 52: 1761-1769.
47. Davis SN, Galassetti P, Wasserman DH, Tate D. Effects of antecedent hypoglycemia on subsequent counterregulatory responses to exercise. Diabetes 2000: 49: 73-81.
48. Galassetti P, Tate D, Neill RA, Richardson A, Leu SY, Davis SN. Effect of differing antecedent hypoglycemia on counterregulatory responses to exercise in type 1 diabetes. Am J Physiol Endocrinol Metab 2006: 290: E1109-E1117.
49. Galassetti P, Mann S, Tate D, Neill RA, Wasserman DH, Davis SN. Effect of morning exercise on counterregulatory responses to subsequent, afternoon exercise. J Appl Physiol 2001: 91: 91-99.
50. Sandoval DA, Guy DL, Richardson MA, Ertl AC, Davis SN. Effects of low and moderate antecedent exercise on counterregulatory responses to subsequent hypoglycemia in type 1 diabetes. Diabetes 2004: 53: 1798-1806.
51. The Diabetes Research in Children Network Study Group. Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. Pediatrics 2005: 147: 528-534.
52. Borghouts LB, Keizer HA. Exercise and insulin sensitivity: A review. Int J Sports Med 2000: 21: 1-12.
53. Jones TW, Porter P, Sherwin RS et al. Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med 1998: 338: 1657-1662.
54. The Diabetes Research in Children Network Study Group. Impaired overnight counterregulatory hormone responses to spontaneous hypoglycemia in children with type 1 diabetes. Pediatr Diabetes 2007: 8: 199-205.
55. Kaufman FR, Austin J, Neinstein A et al. Nocturnal hypoglycemia detected with the continuous glucose monitoring system in pediatric patients with type 1 diabetes. J Pediatr 2002: 141: 625-630.
56. Mc Mahon SK, Ferreira LD, Ratnam N et al. Glucose requirements to maintain euglycemia after moderate-intensity afternoon exercise in adolescents with type 1 diabetes are increased in a biphasic manner. J Clin Endocrinol Metab 2007: 92: 963-968.
57. Robertson K, Adolfsson P, Riddell MC, Scheiner G, Hanas R. Exercise in children and adolescents with diabetes. Pediatr Diabetes 2008: 9: 65-77.
58. Lassarre C, Girard F, Durand J, Raynaud J. Kinetics of human growth hormone during submaximal exercise. J Appl Physiol 1974: 37: 826-830.
59. Stokes KA, Nevill ME, Hall GM, Lakomy HK. Growth hormone responses to repeated maximal cycle ergometer exercise at different pedaling rates. J Appl Physiol 2002: 92: 602-608.
60. Mejri S, Bchir F, Rayana MC, Hamida J, Slama C. Effect of training on GH and IGF-1 responses to a submaximal exercise in football players. Eur J Appl Physiol 2005: 95: 496-503.
61. Ariyasu H, Takaya K, Tagami T et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001: 86: 4753-4758.
62. Patel YC, Srikant CB. Somatostatin mediation of adenohypophysial secretion. Annu Rev Physiol 1986: 48: 551-567.
63. Dall R, Kanaley J, Hansen TK et al. Plasma ghrelin levels during exercise in healthy subjects and in growth hormone-deficient patients. Eur J Endocrinol 2002: 147: 65-70.
64. Maas HCM, de Vries WR, Maitimu I, Bol E, Bowers CY, Koppeschaar HPF. Growth hormone responses during strenuous exercise: The role of GH-releasing hormone and GH-releasing peptide-2. Med Sci Sports Exerc 2000: 32: 1226-1232.
65. Di Luigi L, Conti FG, Casini A et al. Growth hormone and insulin-like growth factor I responses to moderate submaximal acute physical exercise in man: Effects of octreotide, a somatostatin analogue, administration. Int J Sports Med 1997: 18: 257-263.
66. Kozłowski S, Chwalbińska-Moneta J, Vigš M, Kaciuba-Uściłko H, Nazar K. Greater serum GH response to arm than to leg exercise performed at equivalent oxygen uptake. Eur J Appl Physiol 1983: 52: 131-135.
67. Vanhelder WP, Goode RC, Radomski MW. Effect of anaerobic and aerobic exercise of equal duration and work expenditure on plasma growth hormone levels. Eur J Appl Physiol 1984: 52: 255-257.
68. Van Helder W, Casey K, Radomski M. Regulation of growth hormone during exercise by oxygen demand and availability. Eur J Appl Physiol 1987: 56: 628-632.
69. Viru M, Jansson E, Viru A, Sundberg CJ. Effect of restricted blood flow on exercise-induced hormone changes in healthy men. Eur J Appl Physiol 1998: 77: 517-522.
70. Kjaer M, Hanel B, Worm L et al. Cardiovascular and neuroendocrine responses to exercise in hypoxia during impaired neural feedback from muscle. Am J Physiol Regul Integr Comp Physiol 1999: 277: R76-R85.
71. Weltman A, Pritzlaff CJ, Wideman L et al. Exercise-dependent growth hormone release is linked to markers of heightened central adrenergic outflow. J Appl Physiol 2000: 89: 629-635.
72. Kjaer M, Secher NH, Bach FW, Galbo H. Role of motor center activity for hormonal changes and substrate mobilization in humans. Am J Physiol Regul Integr Comp Physiol 1987: 253: R687-R695.
73. Mc Call GE, Grindeland RE, Roy RR, Edgerton VR. Muscle afferent activity modulates bioassayable growth hormone in human plasma. J Appl Physiol 2000: 89: 1137-1141.
74. Christensen SE, Jørgensen OL, Møller N, Orskov H. Characterization of growth hormone release in response to external heating. Comparison to exercise induced release. Acta Endocrinol (Copenh) 1984: 107: 295-301.
75. Galassetti P, Larson J, Iwanaga K, Salsberg SL, Eliakim A, Pontello A. Effect of a high-fat meal on the growth hormone response to exercise in children. J Pediatr Endocrinol Metab 2006: 19: 777-786.
76. Eliakim A, Nemet D, Zaldivar F et al. Reduced exercise-associated response of the GH-IGF-I axis and catecholamines in obese children and adolescents. J Appl Physiol 2006: 100: 1630-1637.
77. Hoos MB, Kuipers H, Gerver W-J, Westerterp KR. Physical activity pattern of children assessed by triaxial accelerometry. Eur J Clin Nutr 2004: 58: 1425-1428.
78. Dunger D, A cerini C. IGF-I and diabetes in adolescence. Diabetes Metab 1998: 24: 101-107.
79. Ji S, Guan R, Frank SJ, Messina JL. Insulin inhibits growth hormone signaling via the growth hormone receptor/JAK2/STAT5B pathway. J Biol Chem 1999: 274: 13434-13442.
80. Danne T, Kordonouri O, Enders I, Weber B. Factors influencing height and weight development in children with diabetes. Results of the Berlin Retinopathy Study. Diabetes Care 1997: 20: 281-285.
81. Holl RW, Grabert M, Heinze E, Sorgo W, Debatin KM. Age at onset and long-term metabolic control affect height in type-1 diabetes mellitus. Eur J Pediatr 1998: 157: 972-977.
82. Backeljauw PF, Underwood LE. Therapy for 6.5-7.5 years with recombinant insulin-like growth factor I in children with growth hormone insensitivity syndrome: A clinical research center study. J Clin Endocrinol Metab 2001: 86: 1504-1510.
83. Veldhuis JD, Roemmich JN, Richmond EJ et al. Endocrine control of body composition in infancy, childhood, and puberty. Endocr Rev 2005: 26: 114-146.
84. Ohlsson C, Bengtsson B-A, Isaksson OG, Andreassen TT, Slootweg MC. Growth hormone and bone. Endocr Rev 1998: 19: 55-79.
85. Musaro A, Mc Cullagh K, Paul A et al. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 2001: 27: 195-200.
86. Kim H, Barton E, Muja N, Yakar S, Pennisi P, Le Roith D. Intact insulin and insulin-like growth factor-I receptor signaling is required for growth hormone effects on skeletal muscle growth and function in vivo. Endocrinology 2005: 146: 1772-1779.
87. Kilgour E, Gout I, Anderson NG. Requirement for phosphoinositide 3-OH kinase in growth hormone signalling to the mitogen-activated protein kinase and p70s6k pathways. Biochem J 1996: 315: 517-522.
88. Argetsinger LS, Hsu GW, Myers MG Jr, Billestrup N, White MF, Carter-Su C. Growth hormone, interferon-gamma, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1. J Biol Chem 1995: 270: 14685-14692.
89. Argetsinger LS, Norstedt G, Billestrup N, White MF, Carter-Su C. Growth hormone, interferon-gamma, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling. J Biol Chem 1996: 271: 29415-29421.
90. Adams TE, Hansen JA, Starr R, Nicola NA, Hilton DJ, Billestrup N. Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling. J Biol Chem 1998: 273: 1285-1287.
91. Pierce AL, Fukada H, Dickhoff WW. Metabolic hormones modulate the effect of growth hormone (GH) on insulin-like growth factor-I (IGF-I) mRNA level in primary culture of salmon hepatocytes. J Endocrinol 2005: 184: 341-349.
92. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 1995: 16: 3-34.
93. Hwa V, Oh Y, Rosenfeld RG. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 1999: 20: 761-787.
94. Chiarelli F, Giannini C, Mohn A. Growth, growth factors and diabetes. Eur J Endocrinol 2004: 151: U109-U117.
95. Iida K, Rosen CJ, Ackert-Bicknell C, Thorner MO. Genetic differences in the IGF-I gene among inbred strains of mice with different serum IGF-I levels. J Endocrinol 2005: 186: 481-489.
96. Baxter RC, Turtle JR. Regulation of hepatic growth hormone receptors by insulin. Biochem Biophys Res Commun 1978: 84: 350-357.
97. Baxter RC, Bryson JM, Turtle JR. Somatogenic receptors of rat liver: regulation by insulin. Endocrinology 1980: 107: 1176-1181.
98. Bereket A, Lang CH, Blethen SL et al. Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1995: 80: 1312-1317.
99. Moran A, Jacobs DR Jr, Steinberger J et al. Association between the insulin resistance of puberty and the insulin-like growth factor-I growth hormone axis. J Clin Endocrinol Metab 2002: 87: 4817-4820.
100. Mc Cusker RH. Controlling insulin-like growth factor activity and the modulation of insulin-like growth factor binding protein and receptor binding. J Dairy Sci 1998: 81: 1790-1800.
101. Brismar K, Fernqvist-Forbes E, Wahren J, Hall K. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab 1994: 79: 872-878.
102. Edge JA, Dunger DB, Matthews DR, Gilbert JP, Smith CP. Increased overnight growth hormone concentrations in diabetic compared with normal adolescents. J Clin Endocrinol Metab 1990: 71: 1356-1362.
103. Batch JA, Baxter RC, Werther G. Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes. J Clin Endocrinol Metab 1991: 73: 964-968.
104. Holly J, Dunger D, Edge J, Smith C, Chard T, Wass J. Insulin-like growth factor binding protein-1 levels in diabetic adolescents and their relationship to metabolic control. Diabet Med 1990: 7: 618-623.
105. Brown M, Ahmed M, Clayton K, Dunger D. Growth during childhood and final height in type 1 diabetes. Diabet Med 1994: 11: 182-187.
106. Hellstrom A, Carlsson B, Niklasson A et al. IGF-I is critical for normal vascularization of the human retina. J Clin Endocrinol Metab 2002: 87: 3413-3416.
107. Amin R, Schultz C, Ong K et al. Low IGF-I and elevated testosterone during puberty in subjects with type 1 diabetes developing microalbuminuria in comparison to normoalbuminuric control subjects: The Oxford regional prospective study. Diabetes Care 2003: 26: 1456-1461.
108. Janssen JA, Jacobs ML, Derkx FH, Weber RF, van der Lely AJ, Lamberts SW. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997: 82: 2809-2815.
109. Hellstrom A, Perruzzi C, Ju M et al. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: Direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A 2001: 98: 5804-5808.
110. Modanlou HD, Gharraee Z, Hasan J, Waltzman J, Nageotte S, Beharry KD. Ontogeny of VEGF, IGF-I, and GH in neonatal rat serum, vitreous fluid, and retina from birth to weaning. Invest Ophthalmol Vis Sci 2006: 47: 738-744.
111. Kraemer RR, Durand RJ, Acevedo EO et al. Rigorous running increases growth hormone and insulin-like growth factor-I without altering ghrelin. Exp Biol Med 2004: 229: 240-246.
112. Eliakim A, Scheett TP, Newcomb R, Mohan S, Cooper DM. Fitness, training, and the growth hormone->insulin-like growth factor I axis in prepubertal girls. J Clin Endocrinol Metab 2001: 86: 2797-2802.
113. Cappon J, Brasel JA, Mohan S, Cooper DM. Effect of brief exercise on circulating insulin-like growth factor I. J Appl Physiol 1994: 76: 2490-2496.
114. Eliakim A, Brasel JA, Mohan S, Barstow TJ, Berman N, Cooper DM. Physical fitness, endurance training, and the growth hormone-insulin- like growth factor I system in adolescent females. J Clin Endocrinol Metab 1996: 81: 3986-3992.
115. Eliakim A, Brasel JA, Mohan S, Wong WLT, Cooper DM. Increased physical activity and the growth hormone-IGF-I axis in adolescent males. Am J Physiol Regul Integr Comp Physiol 1998: 275: R308-R314.
116. Schwarz AJ, Brasel JA, Hintz RL, Mohan S, Cooper DM. Acute effect of brief low- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men. J Clin Endocrinol Metab 1996: 81: 3492-3497.
117. Eliakim A, Moromisato M, Moromisato D, Brasel JA, Roberts C Jr, Cooper DM. Increase in muscle IGF-I protein but not IGF-I mRNA after 5 days of endurance training in young rats. Am J Physiol Regul Integr Comp Physiol 1997: 273: R1557-R1561.
118. Admon G, Weinstein Y, Falk B et al. Exercise with and without an insulin pump among children and adolescents with type 1 diabetes mellitus. EPediatrics 2005: 116: e348-e355.
119. Stokes K, Nevill M, Frystyk J, Lakomy H, Hall G. Human growth hormone responses to repeated bouts of sprint exercise with different recovery periods between bouts. J Appl Physiol 2005: 99: 1254-1261.
120. Kanaley JA, Weltman JY, Veldhuis JD, Rogol AD, Hartman ML, Weltman A. Human growth hormone response to repeated bouts of aerobic exercise. J Appl Physiol 1997: 83: 1756-1761.
121. Ronsen O, Haug E, Pedersen BK, Bahr R. Increased neuroendocrine response to a repeated bout of endurance exercise. Med Sci Sports Exerc 2001: 33: 568-575.
122. Goto K, Higashiyama M, Ishii N, Takamatsu K. Prior endurance exercise attenuates growth hormone response to subsequent resistance exercise. Eur J Appl Physiol 2005: 94: 333-338.
123. Goto K, Ishii N, Mizuno A, Takamatsu K. Enhancement of fat metabolism by repeated bouts of moderate endurance exercise. J Appl Physiol 2007: 102: 2158-2164.
124. Scheett TP, Nemet D, Stoppani J, Maresh CM, Newcomb R, Cooper DM. The effect of endurance-type exercise training on growth mediators and inflammatory cytokines in pre-pubertal and early pubertal males. Pediatr Res 2002: 52: 491-497.
125. Ji LL. Antioxidants and oxidative stress in exercise. Proc Soc Exp Biol Med 1999: 222: 283-292.
126. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001: 414: 813-820.
127. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005: 352: 1685-1695.
128. Johansen J, Harris A, Rychly D, Ergul A. Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice. Cardiovasc Diabetol 2005: 4: 5.
129. Finaud J, Lac G, Filaire E. Oxidative stress: Relationship with exercise and training. Sports Med 2006: 36: 327-358.
130. Kasapis C, Thompson PD. The effects of physical activity on serum C-reactive protein and inflammatory markers: A systematic review. J Am Coll Cardiol 2005: 45: 1563-1569.
131. Mattusch F, Dufaux B, Heine O, Mertens I, Rost R. Reduction of the plasma concentration of C-reactive protein following nine months of endurance training. Int J Sports Med 2000: 21: 21-24.
132. Leeuwenburgh C, Fiebig R, Chandwaney R, Ji LL. Aging and exercise training in skeletal muscle: Responses of glutathione and antioxidant enzyme systems. Am J Physiol Regul Integr Comp Physiol 1994: 267: R439-R445.
133. Leeuwenburgh C, Hollander J, Leichtweis S, Griffiths M, Gore M, Ji LL. Adaptations of glutathione antioxidant system to endurance training are tissue and muscle fiber specific. Am J Physiol Regul Integr Comp Physiol 1997: 272: R363-R369.
134. Pialoux V, Mounier R, Ponsot E et al. Effects of exercise and training in hypoxia on antioxidant/pro-oxidant balance. Eur J Clin Nutr 2006: 60: 1345-1354.
135. Oberbach A, Tonjes A, Kloting N et al. Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance. Eur J Endocrinol 2006: 154: 577-585.
136. Kadoglou NP, Perrea D, Iliadis F, Angelopoulou N, Liapis C, Alevizos M. Exercise reduces resistin and inflammatory cytokines in patients with type 2 diabetes. Diabetes Care 2007: 30: 719-721.
137. Holloszy JO. Biochemical adaptations in muscle. Effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle. J Biol Chem 1967: 242: 2278-2282.
138. Timmons BW, Tarnopolsky MA, Snider DP, Bar-Or O. Immunological changes in response to exercise: Influence of age, puberty, and gender. Med Sci Sports Exerc 2006: 38: 293-304.
139. Rosa JS, Oliver SR, Flores RL et al. Kinetic profiles of 18 systemic pro- and anti-inflammatory mediators during and following exercise in children. J Pediatr Endocrinol Metab 2006: 20: 1293-1305.
140. Rabinovitch A, Suarez-Pinzon WL. Cytokines and their roles in pancreatic islet β-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 1998: 55: 1139-1149.
141. Rosa JS, Flores RL, Oliver SR, Pontello AM, Zaldivar FP, Galassetti PR. Sustained IL-1α, IL-4, and IL-6 elevations following correction of hyperglycemia in children with type 1 diabetes mellitus. Pediatr Diabetes 2008: 9: 9-16.
142. Rosa JS, Oliver SR, Mitsuhashi M et al. Altered kinetics of IL-6 and other inflammatory mediators during exercise in children with type 1 diabetes. J Investig Med 2008: 56: 701-713.
143. Mylona-Karayanni C, Gourgiotis D, Bossios A, Kamper EF. Oxidative stress and adhesion molecules in children with type 1 diabetes mellitus: A possible link. Pediatr Diabetes 2006: 7: 51-59.
144. Powers SK, Criswell D, Lawler J et al. Influence of exercise and fiber type on antioxidant enzyme activity in rat skeletal muscle. Am J Physiol Regul Integr Comp Physiol 1994: 266: R375-R380.
145. Villa-Caballero L, Nava-Ocampo AA, Frati-Munari A, Ponce-Monter H. Oxidative stress, acute and regular exercise: Are they really harmful in the diabetic patient? Med Hypotheses 2000: 55: 43-46.
146. Fenster CP, Weinsier RL, Darley-Usmar VM, Patel RP. Obesity, aerobic exercise, and vascular disease: The role of oxidant stress. Obes Res 2002: 10: 964-968.
147. Davison GW, George L, Jackson SK et al. Exercise, free radicals, and lipid peroxidation in type 1 diabetes mellitus. Free Radic Biol Med 2002: 33: 1543-1551.
148. Simsek M, Naziroglu M, Erdinc A. Moderate exercise with a dietary vitamin C and E combination protects against streptozotocin-induced oxidative damage to the kidney and lens in pregnant rats. Exp Clin Endocrinol Diabetes 2005: 113: 53-59.
149. Armon Y, Cooper DM, Flores R, Zanconato S, Barstow TJ. Oxygen uptake dynamics during high-intensity exercise in children and adults. J Appl Physiol 1991: 70: 841-848.
150. Stentz FB, Umpierrez GE, Cuervo R, Kitabchi AE. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes 2004: 53: 2079-2086.
151. Ostrowski K, Hermann C, Bangash A, Schjerling P, Nielsen JN, Pedersen BK. A trauma-like elevation of plasma cytokines in humans in response to treadmill running. J Physiol 1998: 513: 889-894.
152. Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: A meta-analysis of randomized, controlled trials. Ann Intern Med 2002: 136: 493-503.
153. Carnethon MR, Gidding SS, Nehgme R, Sidney S, Jacobs DR Jr, Liu K. Cardiorespiratory fitness in young adulthood and the development of cardiovascular disease risk factors. JAMA 2003: 290: 3092-3100.
154. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2006: 29: S4-S42.
155. Fan J, Wojnar MM, Theodorakis M, Lang CH. Regulation of insulin-like growth factor (IGF)-I mRNA and peptide and IGF-binding proteins by interleukin-1. Am J Physiol Regul Integr Comp Physiol 1996: 270: R621-R629.
156. Ahmad I, Zaldivar F, Iwanaga K et al. Inflammatory and growth mediators in growing preterm infants. J Pediatr Endocrinol Metab 2007: 20: 387-396.
157. De Benedetti F, Alonzi T, Moretta A et al. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest 1997: 99: 643-650.
158. Neufer PD, Dohm GL. Exercise induces a transient increase in transcription of the GLUT-4 gene in skeletal muscle. Am J Physiol Cell Physiol 1993: 265: C1597-C1603.
159. Kraniou Y, Cameron-Smith D, Misso M, Collier G, Hargreaves M. Effects of exercise on GLUT-4 and glycogenin gene expression in human skeletal muscle. J Appl Physiol 2000: 88: 794-796.
160. Mc Gee SL, Hargreaves M. Exercise and myocyte enhancer factor 2 regulation in human skeletal muscle. Diabetes 2004: 53: 1208-1214.
161. Mc Gee SL, Sparling D, Olson AL, Hargreaves M. Exercise increases MEF2- and GEF DNA-binding activities in human skeletal muscle. FASEB J 2005: 20: 348-349.
162. Holmes B, Dohm GL. Regulation of GLUT4 gene expression during exercise. Med Sci Sports Exerc 2004: 36: 1202-1206.
163. Mc Carty MF. Up-regulation of PPAR-gamma coactivator-1alpha as a strategy for preventing and reversing insulin resistance and obesity. Med Hypotheses 2005: 64: 399-407.
164. Li X, Hansen PA, Xi L, Chandraratna RAS, Burant CF. Distinct mechanisms of glucose lowering by specific agonists for peroxisomal proliferator activated receptor-gamma and retinoic acid X receptors. J Biol Chem 2005: 280: 38317-38327.
165. Leturque A, Loizeau M, Vaulont S, Salminen M, Girard J. Improvement of insulin action in diabetic transgenic mice selectively overexpressing GLUT4 in skeletal muscle. Diabetes 1996: 45: 23-27.
166. Chang SP, Chen YH, Chang WC, Liu IM, Cheng JT. Increase of anti-oxidation by exercise in the liver of obese Zucker rats. Clin Exp Pharmacol Physiol 2004: 31: 506-511.
167. Colombo M, Gregersen S, Kruhoeffer M et al. Prevention of hyperglycemia in Zucker diabetic fatty rats by exercise training: Effects on gene expression in insulin-sensitive tissues determined by high-density oligonucleotide microarray analysis. Metabolism 2005: 54: 1571-1581.
168. Fedele MJ, Hernandez JM, Lang CH et al. Severe diabetes prohibits elevations in muscle protein synthesis after acute resistance exercise in rats. J Appl Physiol 2000: 88: 102-108.
169. Akerstrom T, Steensberg A, Keller P, Keller C, Penkowa M, Pedersen BK. Exercise induces interleukin-8 expression in human skeletal muscle. J Physiol 2005: 563: 507-516.
170. Chan MH, Carey AL, Watt MJ, Febbraio MA. Cytokine gene expression in human skeletal muscle during concentric contraction: Evidence that IL-8, like IL-6, is influenced by glycogen availability. Am J Physiol Regul Integr Comp Physiol 2004: 287: R322-R327.
171. Hiscock N, Chan MH, Bisucci T, Darby IA, Febbraio MA. Skeletal myocytes are a source of interleukin-6 mRNA expression and protein release during contraction: Evidence of fiber type specificity. FASEB J 2004: 18: 992-994.
172. Tomiya A, Aizawa T, Nagatomi R, Sensui H, Kokubun S. Myofibers express IL-6 after eccentric exercise. Am J Sports Med 2004: 32: 503-508.
173. Penkowa M, Keller C, Keller P, Jauffred S, Pedersen BK. Immunohistochemical detection of interleukin-6 in human skeletal muscle fibers following exercise. FASEB J 2003: 17: 2166-2168.
174. Steensberg A, Keller C, Starkie RL, Osada T, Febbraio MA, Pedersen BK. IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle. Am J Physiol Endocrinol Metab 2002: 283: E1272-E1278.
175. Keller C, Keller P, Marshal S, Pedersen BK. IL-6 gene expression in human adipose tissue in response to exercise - effect of carbohydrate ingestion. J Physiol 2003: 550: 927-931.
176. Mahoney DJ, Parise G, Melov S, Safdar A, Tarnopolsky MA. Analysis of global mRNA expression in human skeletal muscle during recovery from endurance exercise. FASEB J 2005: 19: 1498-1500.